Evaluation of Sitagliptin for the treatment of adult patients with type 2 diabetes mellitus: a systematic review of cost-effectiveness

Introduction: Type 2 diabetes mellitus is a global public health problem, being one of the main causes of mortality in Ecuador. Sitagliptin was the first locally marketed incretin-enhancing drug. Countries do not have unlimited resources to meet the health needs of their population, so they must ado...

• Autor principal: Rojas Velasco, Giovanni (author)
• Outros Autores: Solís, Paola (author), Gaona, Richard (author), Nunes, Altacílio (author)
• Formato: article
• Idioma: spa
• Publicado em: 2020
• Assuntos: sitagliptina; diabetes mellitus; costo-efectividad; Diabetes Mellitus Tipo 2; evaluación económica; sitagliptin; cost-effectiveness; Diabetes Mellitus, Type 2; Economic Evaluation
• Acesso em linha: https://revistadigital.uce.edu.ec/index.php/CIENCIAS_MEDICAS/article/view/2661